Primer: Acotec Scientific Holdings (6669 HK) - Oct 2025
Acotec Scientific is a leading domestic player in China's drug-coated balloon (DCB) market, poised to benefit from the growing prevalence of...
176 Views
Acotec/Boston Scientific: Even Higher Proration
I was wrong - the minimum proration is 71.31%, not 65%. Given the irrevocables, this Partial Offer will become unconditional. I'd be a buyer here...
542 Views
Zylox Tonbridge Medical (2190 HK): No More Interventions Needed, Blockages Cleared for Growth
​Zylox-Tonbridge Medical carried forward 2024 momentum, moving into 1H25. New launches and strong market sales capabilities will help drive the...
342 Views
Zylox-Tonbridge Medical Technology (2190.HK) - A Good Alpha-Generating Opportunity for Investors
​Zylox's strong fundamentals and growth potential have not been fully reflected in current valuation due to market conditions, making it a...
510 Views
Pre-IPO Zylox-Tonbridge Medical Technology - Promising Market with Challenges
This insights analyzed Zylox-Tonbridge Medical Technology in terms of the market potential, industry characteristics, business analysis, financial...
519 Views